farzad peiravian - Search Results

Year	Number of Results
2014	4
2015	1
2016	1
2018	4
2019	6
2020	5
2021	11
2022	5
2023	6
2024	0

1

Exploring health seeking behaviors for common cold management.

Keshvari N, Yousefi N, Peiravian F, Sharif Z. Keshvari N, et al. Among authors: peiravian f. Explor Res Clin Soc Pharm. 2023 Jul 11;11:100301. doi: 10.1016/j.rcsop.2023.100301. eCollection 2023 Sep. Explor Res Clin Soc Pharm. 2023. PMID: 37533759 Free PMC article.

2

Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country.

Fathi M, Moradi N, Yousefi N, Peiravian F, Shobeiri N. Fathi M, et al. Among authors: peiravian f. BMC Pulm Med. 2023 Nov 4;23(1):429. doi: 10.1186/s12890-023-02737-5. BMC Pulm Med. 2023. PMID: 37925396 Free PMC article.

3

An investigation into the pharmaceutical advertising in Iranian medical journals.

Yousefi N, Sharif Z, Chahian F, Mombeini T, Peiravian F. Yousefi N, et al. Among authors: peiravian f. J Pharm Policy Pract. 2022 Mar 7;15(1):18. doi: 10.1186/s40545-022-00415-1. J Pharm Policy Pract. 2022. PMID: 35255995 Free PMC article.

4

Impact of the Trade-Related Aspect of Intellectual Property Rights Agreement on Pharmaceutical Industry in Developing Countries: A Scoping Review.

Fathi M, Peiravian F, Yousefi N. Fathi M, et al. Among authors: peiravian f. Iran J Pharm Res. 2021 Fall;20(4):339-351. doi: 10.22037/ijpr.2021.115264.15282. Iran J Pharm Res. 2021. PMID: 35194451 Free PMC article. Review.

5

Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran.

Zarei L, Moradi N, Peiravian F, Hatami-Mazinani N, Mahi-Birjand M, Arabloo J, Babar ZU. Zarei L, et al. Among authors: peiravian f. Int J Equity Health. 2022 Dec 29;21(1):188. doi: 10.1186/s12939-022-01791-5. Int J Equity Health. 2022. PMID: 36581933 Free PMC article.

6

The cost of dispensing errors in Iranian health system: a retrospective evaluation.

Yousefi N, Asadi F, Sharif Z, Khani A, Baymaninezhad D, Salamzade J, Peiravian F. Yousefi N, et al. Among authors: peiravian f. Int J Qual Health Care. 2022 Nov 28;34(4):mzac083. doi: 10.1093/intqhc/mzac083. Int J Qual Health Care. 2022. PMID: 36416568

7

Parallel import: is it worth?

Peiravian F. Peiravian F. Iran J Pharm Res. 2014 Fall;13(4):1111-4. Iran J Pharm Res. 2014. PMID: 25587298 Free PMC article. No abstract available.

8

How does external reference pricing work in developing countries: evidence from Iran.

Babaie F, Motevalli MH, Mehralian G, Peiravian F, Yousefi N. Babaie F, et al. Among authors: peiravian f. Front Pharmacol. 2023 Jun 20;14:1034229. doi: 10.3389/fphar.2023.1034229. eCollection 2023. Front Pharmacol. 2023. PMID: 37408767 Free PMC article.

9

Main drivers of diabetes pharmaceuticals expenditures: evidence from OECD countries and Iran.

Akbarpour Z, Zarei L, Varahrami V, Peiravian F, Yousefi N. Akbarpour Z, et al. Among authors: peiravian f. J Diabetes Metab Disord. 2022 Dec 22;22(1):431-442. doi: 10.1007/s40200-022-01161-6. eCollection 2023 Jun. J Diabetes Metab Disord. 2022. PMID: 37255794 Free PMC article.

10

How Do Iranian Stakeholders Think About Pharmaceutical Managed Entry Agreements?

Shobeiri N, Peiravian F, Yousefi N. Shobeiri N, et al. Among authors: peiravian f. Iran J Pharm Res. 2022 May 4;21(1):e126916. doi: 10.5812/ijpr-126916. eCollection 2022 Dec. Iran J Pharm Res. 2022. PMID: 36060922 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Results by year